Should psychedelic drugs be decriminalized in Mass.? Advocates see opening
Marijuana Stocks, Finance, & InvestingUncategorized February 6, 2021 MJ Shareholders
Somerville in January became the first jurisdiction in Massachusetts to move toward decriminalizing plant-based psychedelic drugs, with city leaders voting unanimously to recognize the medical uses of natural entheogens — including psilocybin, the active ingredient in “magic mushrooms” — and make them among the lowest enforcement priorities for local police.
Fresh off that victory, advocates for decriminalizing such drugs are now bringing their fight to Beacon Hill.
State Representative Mike Connolly, whose district includes large swaths of Somerville and Cambridge and who has been working with the reformers, told the Globe he is planning to file a preliminary bill that would create a committee of public officials, scientists, criminal justice experts, and others to study whether Massachusetts should decriminalize natural psychedelics and legalize their administration in therapeutic settings statewide.
Read More
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers